Article Information
History
- March 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Michael B. Hall1,
- Marie Sylvianne Rabodoarivelo2,
- Anastasia Koch3,4,
- Anzaan Dippenaar5,6,
- Sophie George7,
- Melanie Grobbelaar5,
- Robin Warren5,
- Timothy Walker8,
- Helen Cox4,9,10,
- Sebastien Gagneux11,12,
- Derrick Crook7,
- Tim Peto7,
- Niaina Rakotosamimanana2,
- Simon Grandjean Lapierre2,13,14,* and
- Zamin Iqbal1,*,†
- 1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, United Kingdom
- 2Mycobacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar
- 3SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit & DST/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- 4Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- 5Department of Science and Innovation-National Research Foundation Centre for Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
- 6Tuberculosis Omics Research Consortium, Family Medicine and Population Health, Institute of Global Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
- 7Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford University, Oxford, United Kingdom
- 8Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam
- 9Division of Medical Microbiology, Department of Pathology, University of Cape Town
- 10Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town
- 11Swiss Tropical and Public Health Institute, Basel Switzerland
- 12University of Basel, Basel, Switzerland
- 13Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada
- 14Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
- ↵† Corresponding author; email: zi{at}ebi.ac.uk